DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Mira JA, Rivero-Juarez A, Lopez-Cortes LF. et al.
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;
56: 1646-1653
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.